We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Surgery Reverses Obesity-Related Hypogonadism

By HospiMedica International staff writers
Posted on 05 Jun 2018
A new study shows that weight loss after obesity surgery can rapidly restore testosterone production and sex drive in morbidly obese men.

Researchers at the University of Padova (Italy) conducted a study involving 29 obese men (average age 40.5 years, average body mass index (BMI) 43.4 kg/m2) who underwent a bariatric sleeve gastrectomy procedure. More...
Blood tests were performed before and one month after surgery to measure total plasma testosterone, the sex hormones dihydrotestosterone (DHT), estradiol, luteinising hormone (LH), follicle-stimulating hormone (FSH), sex hormone binding globulin (SHBG), prostatic-specific antigen (PSA), and leptin. A group of 19 healthy age-matched, non-obese, male subjects served as a control.

Among the obese subjects, 51.6% suffered from hypogonadism, and of those who had subnormal total testosterone, those with metabolic syndrome (45.2%) showed lower plasma testosterone than men without metabolic syndrome. BMI and waist circumference were found to be negatively correlated with total testosterone and plasma LH levels. The obese males had lower plasma testosterone (10.8 nmol/L) than healthy subjects (15.7 nmol/L), higher estradiol levels, and lower LH and FSH levels. No differences were observed between the two groups in their DHT and PSA levels.

The results revealed that one month after the sleeve gastrectomy procedure, obese subjects showed a significant weight reduction (averaging 17.2 kg) and the proportion with hypogonadism had fallen to just 11.6%. At the same time, average testosterone levels increased by 85%, to a level greater than that observed in the healthy control group (18.9 nmol/L), and estradiol levels fell by 35%. Surprisingly, PSA levels rose by 70%. The study was presented at the European Congress on Obesity (ECO), held during May 2018 in Vienna (Austria).

“Obesity in men is associated with hypogonadism, a condition in which production of testosterone is reduced, while estrogen levels are elevated,” said senior author Professor Marco Rossato, MD, and colleagues. “These effects seem to be the result of excess body fat interfering with sex steroid metabolism which leads to increased aromatization of androgens (such as testosterone) into estrogens within the adipose tissue itself. It follows that weight loss should improve this hormonal imbalance, and contribute to a reversal of hypogonadism.”

Hypogonadism in men refers to a diminished functional activity of the gonads, resulting in diminished testosterone biosynthesis. Other hormones produced by the gonads that hypogonadism can decrease include progesterone, DHEA, anti-Müllerian hormone, activin, and inhibin. In men, it can cause reduced body hair and beard, enlarged breasts, loss of muscle, and sexual difficulties.

Related Links:
University of Padova


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Pediatric Mask
Respire SOFT
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie MellonImage: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie Mellon University)University)

Portable Artificial Lung Technology Could Reshape Care for Chronic Lung Disease

Chronic lung disease can leave patients dependent on prolonged mechanical ventilation or awaiting transplantation, both of which carry substantial morbidity and healthcare costs. Ventilatory support may... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.